Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H2O2 responsive and oxygen-producing nanohybrids

An ideal cancer therapeutic strategy should not only reverse multidrug resistance (MDR), but also prevent cancer metastasis. In this study, bovine serum albumin (BSA) was hybridized with Mn2+via biomineralization to develop a hybrid protein oxygen nanocarrier, which contained doxorubicin (DOX) and s...

Full description

Saved in:
Bibliographic Details
Published in:Journal of materials chemistry. B, Materials for biology and medicine Materials for biology and medicine, 2019, Vol.7 (31), p.4784-4793
Main Authors: Du, Bin, Ding, Xiaoyu, Wang, Hui, Du, Qian, Xu, Tianguo, Huang, Jingshu, Zhou, Jie, Cheng, Genyang
Format: Article
Language:English
Subjects:
Animal models
Bovine serum albumin
Cancer
Cell culture
Chemoresistance
Chemotherapy
Doxorubicin
Fluorescence
Gene therapy
Growth factors
Hydrogen peroxide
Hypoxia
Lungs
Magnetic resonance imaging
Manganese dioxide
Metastases
Metastasis
Mineralization
Multidrug resistance
Oxygen
Serum albumin
siRNA
Strategy
Tumors
Vascular endothelial growth factor
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An ideal cancer therapeutic strategy should not only reverse multidrug resistance (MDR), but also prevent cancer metastasis. In this study, bovine serum albumin (BSA) was hybridized with Mn2+via biomineralization to develop a hybrid protein oxygen nanocarrier, which contained doxorubicin (DOX) and small interfering RNA (siRNA). The nanohybrid has the function of producing oxygen and chemotherapy synergistic gene therapy. FA–BSA–MnO2/DOX/siRNA was favorable for increasing the sensitivity of MCF-7/ADR cells to DOX. Moreover, FA–BSA–MnO2/DOX/siRNA NPs were also able to generate oxygen (O2) by reaction with endogenous hydrogen peroxide (H2O2) in tumor, thereby down-regulating the expression of hypoxia inducible factor-1α (HIF-1α), and then the expression of the vascular endothelial growth factor (VEGF) was down-regulated. At the same time, siRNA can directly or indirectly suppress the expression of the VEGF and HIF-1α. Therefore, the combination of two pathways and the chemo-gene therapy strategy can interactively overcome tumor hypoxia-associated MDR and metastasis, which will enhance therapeutic efficacy in the future.
ISSN:2050-750X
2050-7518
DOI:10.1039/c9tb00546c